Engineers Journal, December 5, 2017
Independent Portuguese APIs producer Hovione has bought 75% of Hisyn Pharmaceutical in China's Zhejiang province, which had been supplying it with intermediates for some time. This transaction is already operational after the Zhejiang authorities issued the necessary business licence.
With this buy come development laboratories in Shanghai and a 22,000m2 API facility on a nine-hectare plot, employing 181. Hovione will produce its two largest volume products here.